Here’s What You Should Know About Pfizer’s New COVID Drug Paxlovid

Prior to anyone getting involved with the new Pfizer COVID drug Paxlovid, there are quite a few things that you should consider instead of buying into the mainstream media narrative.

The pro-drug industry mainstream media are gushing about Pfizer’s new antiviral COVID medication pills, which were recently authorized by the US FDA.

Paxlovid, a drug approved by the FDA for use in patients aged 12 and upwards who’ve already tested positive with COVID-19 and are at high risk, has acquired an emergency use authorization.

Now would be the opportunity to discuss about Paxlovid in a reasonable and concise way. First and foremost, everyone should be aware that, like with COVID vaccinations, there was very little testing of this product’s short- and long-term security. Testing a new medication thoroughly should take several months, if not years.

The only actually positive news regarding this new drug is that it is in fact an actual combination of drugs.

Here are a few quick summaries of this new product:

It was authorized by the FDA without any outside consultations, thorough assessments of test data, or public input. Almost all of the regulatory activity was carried out behind closed doors.

For  Pfizer this would be fantastic news. But it’s not good for the public. Earlier, Pfizer was also accused of manipulating COVID vaccine trial protocols to obtain emergency FDA authorisation for children.

It’s worth noting that just 21% of patients in the studies had a comorbidity, when in fact, 94 percent of COVID deaths have at least one comorbidity, with an average of four underlying medical disorders.

Protease enzymes are required for the virus to properly infect by completing the cycle before taking over the cell, according to antiviral science.

Paxlovid, or any other medicine categorized as a ‘Protease Inhibitor,’ inhibits or reduces the protease enzyme, causing the virus to be inhibited. Paxlovid prevents the 3CLPro protease from fragmenting the lengthy protein.

The virus is unable to determine which bits should be cut out and assembled. It is unable to duplicate itself. The COVID infection is readily eradicated.

Ivermectin is the most efficient and confirmed protease inhibitor in use globally, irrespective what the government claims. Ivermectin, like Paxlovid, inhibits the protease enzyme, but… Ivermectin has advantages in COVID treatment that Paxlovid does not have.

Ivermectin also has anti-coagulant and anti-inflammatory properties, which are both seen in COVID infections. And IVM has already been used reliably for decades, with numerous medical research and clinical outcomes demonstrating its antiviral and anti-inflammatory efficacy.

Paxlovid must be used in conjunction with Ritonavir, an HIV/AIDS medicine that prevents Paxlovid from being broken down so that it can inhibit or decrease the enzyme, disrupting the viral life cycle.

Ritonavir helps Paxlovid stay active in the body by acting as a booster. Ritonavir has its own black box warning, and adverse effects comprise liver, pancreatic, and heart problems that can be fatal. Is it true that the general public wants to take an HIV/AIDS drug?

A five-day treatment regimen consists of 20 Paxlovid pills and 10 Ritonavir pills. Taking 6 medicines daily can cause issues for many of the older folks specifically.

Paxlovid lowers hospitalization/death by 89 percent for persons with established COVID infection, according to a press release from Pfizer, when administered within three days of symptom start. So, in the therapy group, 5 of 697 hospitalizations resulted in no deaths, compared to 44/682 hospitalizations resulting in 9 deaths.

Consider the statement that this medicine combination should be taken within three days after symptom start. Here are some of the major issues that ordinary people face: how can you distinguish COVID symptoms from flu or cold symptoms; how can you get a quick test; how can you contact your doctor within a day or two and determine whether you really have COVID (no drug interactions) and, if so, get a prescription; how can you get the prescription filled quickly? None of these issues are simple to deal with and resolve. For nearly everyone, this new combination treatment is unrealistic and unworkable.

A 10-fold reduction in viral load at day 5 compared to placebo was also reported, demonstrating significant action against SARS-CoV-2 and (allegedly) the highest viral load reduction recorded to date for a COVID-19 oral antiviral drug.

It would have been fascinating to compare the Pfizer medicine to an ivermectin treatment.

How does the Pfizer medicine stack up against the Dr. George Fareed and Dr. Brian Tyson protocol, for example? Fareed and Tyson, on the other hand, had a lot more patients (about 7,000) on the drug combination, but they had fewer hospitalizations (4) as well as the same amount of fatalities (0).

As a result, the Fareed and Tyson protocol is far superior. And, after billions of usage around the world, IVM’s safety protocol is significantly more validated than Pfizer’s.

See this article for a detailed comparison of IVM and Paxlovid. Ivermectin’s capacity to block 3CL protease has been scientifically shown.

Dysgeusia (taste disturbance), diarrhoea, and vomiting were the most prevalent side effects reported during treatments and up to 34 days following the final dosage of Paxlovid. What, on the other hand, are the chances of more serious side effects appearing months or years later?

Paxlovid should not be combined with certain other medications, either because of its action, which can cause dangerous rises in patients’ blood levels, or because some medicines can inhibit Paxlovid’s function.

The proposed conditions for use contain a list of drugs that should not be used with Paxlovid. This list contains a significant number of medications and supplements that are used by many millions of people, including Lipitor and St. John’s Wort, for example. Paxlovid should not be used in those who have significant kidney or liver disease.

Paxlovid should not be used through pregnancy or in women who are trying to conceive and are not utilising contraceptives. During treatment, breastfeeding should be ceased.

These recommendations are based on animal research that demonstrate large doses of Paxlovid could potentially affect the fetus’s growth.

Pfizer CEO Bourla recently stated that the company will be able to develop 80 million courses in 2022, with 30 million accessible in the first half of the year. That is insufficient to service the many millions of Americans who are experiencing symptoms and have a positive diagnosis.

A Pfizer representative told the Wall Street Journal that tens of thousands of the tablets will arrive in the US before the end of 2021, with hundreds of thousands more due at the start of 2022.

According to the publication, the US government is paying Pfizer $5.3 billion for 10 million treatment cycles that will be provided by the end of next year. Will $530 per course be covered by medical insurance?

Always keep an eye on the money. SVB Leerink analyst Geoffrey Porges forecasted $24.2 billion in revenues for the medication in 2022 a month ago. According to Cantor Fitzgerald analyst Louise Chen, Pfizer might be looking at $50 billion in peak pandemic vaccine and medicine sales, when combined with the business’s megablockbuster COVID-19 vaccine, it’s really no surprise that some Pfizer executives have amassed fortunes in the billions of dollars.

Do you want to do what’s best for yourself or what’s best for Pfizer?